Thomas Meyer
Concepts (367)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Water | 29 | 2020 | 394 | 8.040 |
Why?
| Ruthenium | 22 | 2020 | 31 | 5.640 |
Why?
| Organometallic Compounds | 21 | 2014 | 98 | 4.790 |
Why?
| Catalysis | 29 | 2020 | 288 | 2.960 |
Why?
| Oxidation-Reduction | 41 | 2020 | 912 | 2.920 |
Why?
| Protons | 12 | 2016 | 72 | 2.690 |
Why?
| Electron Transport | 16 | 2016 | 108 | 2.210 |
Why?
| Titanium | 10 | 2013 | 72 | 2.170 |
Why?
| Electrodes | 13 | 2020 | 97 | 1.870 |
Why?
| Oxygen | 8 | 2020 | 827 | 1.660 |
Why?
| Electrochemistry | 14 | 2017 | 77 | 1.530 |
Why?
| Electron Transport Complex IV | 4 | 2016 | 53 | 1.430 |
Why?
| Electrochemical Techniques | 7 | 2020 | 45 | 1.420 |
Why?
| Coordination Complexes | 6 | 2020 | 11 | 1.320 |
Why?
| Electrons | 9 | 2013 | 71 | 1.290 |
Why?
| Tin Compounds | 5 | 2020 | 16 | 1.250 |
Why?
| Molecular Structure | 18 | 2014 | 429 | 1.240 |
Why?
| Photochemical Processes | 6 | 2013 | 98 | 1.110 |
Why?
| Alu Elements | 4 | 2016 | 26 | 1.110 |
Why?
| 2,2'-Dipyridyl | 3 | 2013 | 6 | 1.100 |
Why?
| Models, Chemical | 6 | 2013 | 246 | 1.090 |
Why?
| Hylobates | 3 | 2016 | 8 | 1.070 |
Why?
| Solar Energy | 4 | 2013 | 32 | 1.060 |
Why?
| Chlorides | 2 | 2015 | 130 | 0.890 |
Why?
| Surface Properties | 10 | 2017 | 381 | 0.870 |
Why?
| Pyridines | 5 | 2013 | 417 | 0.870 |
Why?
| Copper | 2 | 2015 | 99 | 0.850 |
Why?
| Benzoquinones | 2 | 2014 | 44 | 0.840 |
Why?
| Oligopeptides | 3 | 2013 | 231 | 0.820 |
Why?
| Nanostructures | 3 | 2013 | 91 | 0.820 |
Why?
| Amides | 2 | 2014 | 87 | 0.810 |
Why?
| Coloring Agents | 3 | 2020 | 71 | 0.800 |
Why?
| Peptides | 5 | 2014 | 844 | 0.760 |
Why?
| Polymers | 2 | 2017 | 448 | 0.740 |
Why?
| Ammonia | 2 | 2019 | 56 | 0.670 |
Why?
| Metal Nanoparticles | 4 | 2015 | 69 | 0.660 |
Why?
| Osmium | 2 | 2013 | 4 | 0.660 |
Why?
| Kinetics | 11 | 2014 | 1528 | 0.640 |
Why?
| Nitrogen Cycle | 1 | 2019 | 10 | 0.640 |
Why?
| Genome | 8 | 2018 | 260 | 0.610 |
Why?
| Long Interspersed Nucleotide Elements | 2 | 2016 | 25 | 0.610 |
Why?
| Paracoccus denitrificans | 2 | 2015 | 3 | 0.600 |
Why?
| Enzymes, Immobilized | 2 | 2015 | 25 | 0.590 |
Why?
| Photochemistry | 5 | 2012 | 123 | 0.570 |
Why?
| Phylogeny | 4 | 2014 | 783 | 0.570 |
Why?
| Gold | 3 | 2015 | 102 | 0.570 |
Why?
| Light | 3 | 2020 | 331 | 0.570 |
Why?
| Photosynthesis | 4 | 2014 | 75 | 0.570 |
Why?
| Minisatellite Repeats | 1 | 2016 | 36 | 0.540 |
Why?
| Hydroquinones | 2 | 2012 | 27 | 0.500 |
Why?
| Thermus thermophilus | 2 | 2014 | 9 | 0.490 |
Why?
| Hydrogen-Ion Concentration | 6 | 2015 | 502 | 0.480 |
Why?
| Silver | 1 | 2015 | 27 | 0.470 |
Why?
| Chlorine | 1 | 2015 | 62 | 0.470 |
Why?
| Cytochrome b Group | 1 | 2014 | 16 | 0.470 |
Why?
| Proline | 3 | 2013 | 72 | 0.460 |
Why?
| Oxides | 2 | 2013 | 40 | 0.460 |
Why?
| Carbon Dioxide | 2 | 2012 | 205 | 0.440 |
Why?
| Ferric Compounds | 1 | 2014 | 41 | 0.440 |
Why?
| NAD | 1 | 2014 | 63 | 0.440 |
Why?
| Fluorine | 1 | 2013 | 15 | 0.430 |
Why?
| Polystyrenes | 1 | 2013 | 36 | 0.430 |
Why?
| Cobalt | 1 | 2013 | 43 | 0.420 |
Why?
| Polymerization | 1 | 2013 | 118 | 0.410 |
Why?
| Biofuels | 1 | 2012 | 16 | 0.410 |
Why?
| Singlet Oxygen | 1 | 2012 | 19 | 0.410 |
Why?
| Diphosphonates | 1 | 2012 | 51 | 0.400 |
Why?
| Benzyl Alcohol | 1 | 2012 | 11 | 0.390 |
Why?
| Carbon Monoxide | 1 | 2012 | 62 | 0.390 |
Why?
| Hydroxides | 1 | 2011 | 25 | 0.390 |
Why?
| Nanoparticles | 3 | 2013 | 308 | 0.380 |
Why?
| Cytochromes c1 | 1 | 2011 | 1 | 0.380 |
Why?
| Cytochrome c Group | 1 | 2011 | 35 | 0.370 |
Why?
| Papillomaviridae | 2 | 2019 | 100 | 0.370 |
Why?
| Tryptophan | 1 | 2011 | 134 | 0.360 |
Why?
| Indium | 1 | 2010 | 8 | 0.350 |
Why?
| Photolysis | 1 | 2011 | 78 | 0.350 |
Why?
| Tin | 1 | 2010 | 8 | 0.350 |
Why?
| Photosystem II Protein Complex | 2 | 2007 | 16 | 0.350 |
Why?
| Ruthenium Compounds | 1 | 2010 | 1 | 0.340 |
Why?
| Nitrogen | 2 | 2019 | 143 | 0.340 |
Why?
| Models, Molecular | 7 | 2013 | 1359 | 0.320 |
Why?
| Papillomavirus Infections | 2 | 2019 | 258 | 0.300 |
Why?
| Recombination, Genetic | 4 | 2016 | 175 | 0.280 |
Why?
| Molecular Conformation | 5 | 2013 | 132 | 0.270 |
Why?
| Deoxycytidine | 4 | 2014 | 137 | 0.250 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2014 | 1356 | 0.250 |
Why?
| Energy Transfer | 3 | 2013 | 47 | 0.230 |
Why?
| Solvents | 1 | 2004 | 104 | 0.220 |
Why?
| Carcinoma, Basal Cell | 1 | 2004 | 67 | 0.210 |
Why?
| Evolution, Molecular | 6 | 2014 | 424 | 0.210 |
Why?
| Amines | 1 | 2003 | 34 | 0.210 |
Why?
| Luminescence | 2 | 2012 | 33 | 0.200 |
Why?
| Organ Transplantation | 1 | 2004 | 157 | 0.190 |
Why?
| Spectrophotometry | 2 | 2012 | 47 | 0.190 |
Why?
| Lasers | 2 | 2012 | 121 | 0.180 |
Why?
| Thermodynamics | 4 | 2007 | 378 | 0.180 |
Why?
| Hydrogen Bonding | 3 | 2016 | 143 | 0.180 |
Why?
| Quantum Theory | 2 | 2011 | 78 | 0.180 |
Why?
| DNA Transposable Elements | 2 | 2014 | 97 | 0.180 |
Why?
| Biomimetics | 1 | 2020 | 36 | 0.170 |
Why?
| Edetic Acid | 1 | 2020 | 44 | 0.170 |
Why?
| Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 953 | 0.170 |
Why?
| Sodium Nitrite | 1 | 2020 | 37 | 0.170 |
Why?
| Lung Neoplasms | 4 | 2011 | 2148 | 0.160 |
Why?
| Circular Dichroism | 2 | 2013 | 135 | 0.160 |
Why?
| Retroelements | 5 | 2014 | 38 | 0.160 |
Why?
| HMGN1 Protein | 1 | 2018 | 1 | 0.160 |
Why?
| Carcinoma, Squamous Cell | 1 | 2004 | 575 | 0.160 |
Why?
| Blood | 1 | 2019 | 93 | 0.150 |
Why?
| Molecular Sequence Data | 6 | 2014 | 2741 | 0.150 |
Why?
| Animals | 16 | 2020 | 31162 | 0.150 |
Why?
| Imidazoles | 1 | 2018 | 203 | 0.140 |
Why?
| Crystallography, X-Ray | 2 | 2013 | 402 | 0.140 |
Why?
| Buffers | 1 | 2017 | 53 | 0.140 |
Why?
| Skin Neoplasms | 1 | 2004 | 755 | 0.140 |
Why?
| Pseudomonas stutzeri | 1 | 2016 | 1 | 0.140 |
Why?
| Rhodobacter sphaeroides | 1 | 2016 | 7 | 0.140 |
Why?
| Vibrio cholerae | 1 | 2016 | 9 | 0.140 |
Why?
| Electric Power Supplies | 2 | 2013 | 46 | 0.130 |
Why?
| Dendritic Cells | 1 | 2018 | 432 | 0.130 |
Why?
| Phenothiazines | 2 | 2006 | 7 | 0.120 |
Why?
| Silver Compounds | 1 | 2015 | 3 | 0.120 |
Why?
| Time Factors | 4 | 2013 | 6032 | 0.120 |
Why?
| Potentiometry | 2 | 2016 | 2 | 0.120 |
Why?
| Cerium | 1 | 2015 | 13 | 0.120 |
Why?
| Chemical Precipitation | 1 | 2015 | 37 | 0.120 |
Why?
| Carbonates | 1 | 2015 | 6 | 0.120 |
Why?
| HeLa Cells | 1 | 2016 | 553 | 0.120 |
Why?
| Karyotype | 1 | 2014 | 13 | 0.120 |
Why?
| Chemoradiotherapy, Adjuvant | 1 | 2014 | 40 | 0.120 |
Why?
| Solutions | 1 | 2015 | 142 | 0.120 |
Why?
| Pan troglodytes | 3 | 2008 | 47 | 0.120 |
Why?
| Epigenesis, Genetic | 1 | 2018 | 515 | 0.110 |
Why?
| Pancreatic Neoplasms | 2 | 2014 | 721 | 0.110 |
Why?
| Bacteria | 1 | 2020 | 716 | 0.110 |
Why?
| Fluorouracil | 3 | 2010 | 151 | 0.110 |
Why?
| Particle Size | 2 | 2011 | 310 | 0.110 |
Why?
| Ions | 1 | 2013 | 59 | 0.110 |
Why?
| Enzyme Activation | 1 | 2015 | 752 | 0.100 |
Why?
| Pancreatectomy | 1 | 2014 | 167 | 0.100 |
Why?
| Strepsirhini | 1 | 2012 | 2 | 0.100 |
Why?
| Lipid Bilayers | 1 | 2013 | 94 | 0.100 |
Why?
| Phosphoric Acids | 1 | 2012 | 16 | 0.100 |
Why?
| Tantalum | 1 | 2012 | 3 | 0.100 |
Why?
| Anthracenes | 1 | 2012 | 27 | 0.100 |
Why?
| Asia, Southeastern | 1 | 2012 | 10 | 0.100 |
Why?
| Acrylates | 1 | 2012 | 45 | 0.100 |
Why?
| Mutagenesis, Insertional | 1 | 2012 | 61 | 0.100 |
Why?
| Luminescent Agents | 1 | 2012 | 7 | 0.100 |
Why?
| Zinc | 1 | 2015 | 257 | 0.100 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 160 | 0.100 |
Why?
| Cholesterol | 1 | 2013 | 365 | 0.100 |
Why?
| Quartz Crystal Microbalance Techniques | 1 | 2011 | 2 | 0.100 |
Why?
| Iridium | 1 | 2011 | 7 | 0.100 |
Why?
| Neoplasm Recurrence, Local | 2 | 2014 | 848 | 0.100 |
Why?
| Geography | 1 | 2012 | 173 | 0.100 |
Why?
| Molecular Dynamics Simulation | 1 | 2013 | 200 | 0.090 |
Why?
| Semiconductors | 1 | 2011 | 34 | 0.090 |
Why?
| Biology | 1 | 2012 | 71 | 0.090 |
Why?
| Cytokines | 1 | 2018 | 1795 | 0.090 |
Why?
| Selenium Compounds | 1 | 2011 | 21 | 0.090 |
Why?
| Data Mining | 1 | 2012 | 100 | 0.090 |
Why?
| Ligands | 3 | 2016 | 553 | 0.090 |
Why?
| Cadmium Compounds | 1 | 2011 | 30 | 0.090 |
Why?
| Bacterial Proteins | 1 | 2016 | 733 | 0.090 |
Why?
| Glutamates | 1 | 2011 | 55 | 0.090 |
Why?
| Genetic Loci | 1 | 2012 | 256 | 0.090 |
Why?
| Anti-Bacterial Agents | 1 | 2020 | 1465 | 0.090 |
Why?
| Guanine | 1 | 2011 | 76 | 0.090 |
Why?
| Computational Biology | 2 | 2012 | 527 | 0.090 |
Why?
| Carboplatin | 1 | 2011 | 134 | 0.090 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2012 | 472 | 0.090 |
Why?
| Organoplatinum Compounds | 1 | 2010 | 37 | 0.090 |
Why?
| Humans | 22 | 2019 | 113531 | 0.090 |
Why?
| Leucovorin | 1 | 2010 | 43 | 0.080 |
Why?
| Survival Analysis | 4 | 2011 | 1203 | 0.080 |
Why?
| Dimerization | 1 | 2010 | 175 | 0.080 |
Why?
| DNA, Viral | 2 | 2019 | 345 | 0.080 |
Why?
| Genome, Human | 2 | 2008 | 342 | 0.080 |
Why?
| Polymerase Chain Reaction | 1 | 2012 | 984 | 0.080 |
Why?
| Metals | 1 | 2010 | 105 | 0.080 |
Why?
| Interspersed Repetitive Sequences | 1 | 2008 | 4 | 0.080 |
Why?
| Chromosome Inversion | 1 | 2008 | 16 | 0.080 |
Why?
| Models, Statistical | 1 | 2012 | 593 | 0.080 |
Why?
| Chromosomes | 1 | 2008 | 85 | 0.080 |
Why?
| Stereoisomerism | 2 | 2011 | 90 | 0.070 |
Why?
| Radiotherapy, Conformal | 2 | 2006 | 68 | 0.070 |
Why?
| Membranes | 1 | 2007 | 18 | 0.070 |
Why?
| Pyrazoles | 1 | 2011 | 361 | 0.070 |
Why?
| Hydrogen | 1 | 2008 | 59 | 0.070 |
Why?
| Polyethylene Glycols | 1 | 2012 | 557 | 0.070 |
Why?
| Temperature | 1 | 2010 | 557 | 0.070 |
Why?
| Cercopithecidae | 1 | 2007 | 7 | 0.070 |
Why?
| Enzymes | 1 | 2007 | 62 | 0.070 |
Why?
| Aged | 9 | 2014 | 18944 | 0.070 |
Why?
| Genetic Variation | 2 | 2008 | 854 | 0.070 |
Why?
| Macaca mulatta | 1 | 2007 | 130 | 0.070 |
Why?
| Barotrauma | 1 | 2006 | 1 | 0.070 |
Why?
| Antineoplastic Agents | 2 | 2010 | 1872 | 0.070 |
Why?
| Bronchogenic Cyst | 1 | 2006 | 6 | 0.070 |
Why?
| Explosions | 1 | 2006 | 11 | 0.070 |
Why?
| Embolism, Air | 1 | 2006 | 11 | 0.070 |
Why?
| Luminescent Measurements | 2 | 2003 | 73 | 0.070 |
Why?
| Intracranial Embolism | 1 | 2006 | 29 | 0.070 |
Why?
| Aircraft | 1 | 2006 | 26 | 0.070 |
Why?
| Database Management Systems | 1 | 2006 | 47 | 0.070 |
Why?
| Models, Theoretical | 1 | 2010 | 505 | 0.070 |
Why?
| Tetrazoles | 1 | 2006 | 32 | 0.070 |
Why?
| Prevalence | 3 | 2014 | 2244 | 0.070 |
Why?
| Signal Transduction | 1 | 2018 | 4439 | 0.060 |
Why?
| Liver Neoplasms | 1 | 2010 | 504 | 0.060 |
Why?
| Drug Administration Schedule | 2 | 2010 | 712 | 0.060 |
Why?
| Tyrosine | 1 | 2006 | 203 | 0.060 |
Why?
| Spectrophotometry, Ultraviolet | 2 | 2016 | 73 | 0.060 |
Why?
| Databases, Genetic | 1 | 2006 | 205 | 0.060 |
Why?
| Tumor Suppressor Proteins | 1 | 2007 | 283 | 0.060 |
Why?
| Bile Ducts, Extrahepatic | 1 | 2004 | 24 | 0.060 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 367 | 0.060 |
Why?
| Iron | 1 | 2006 | 232 | 0.060 |
Why?
| Isotopes | 1 | 2004 | 27 | 0.060 |
Why?
| Anthraquinones | 1 | 2004 | 9 | 0.060 |
Why?
| Bile Duct Neoplasms | 1 | 2004 | 56 | 0.060 |
Why?
| Middle Aged | 8 | 2014 | 26552 | 0.060 |
Why?
| Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 76 | 0.060 |
Why?
| Structure-Activity Relationship | 2 | 2016 | 497 | 0.060 |
Why?
| Receptors, Vascular Endothelial Growth Factor | 1 | 2004 | 103 | 0.060 |
Why?
| Nerve Tissue Proteins | 1 | 2007 | 521 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2003 | 99 | 0.050 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2006 | 209 | 0.050 |
Why?
| Colorectal Neoplasms | 1 | 2010 | 592 | 0.050 |
Why?
| Purines | 1 | 2004 | 158 | 0.050 |
Why?
| Biodiversity | 1 | 2006 | 347 | 0.050 |
Why?
| Protein Structure, Secondary | 1 | 2004 | 324 | 0.050 |
Why?
| Topotecan | 1 | 2003 | 10 | 0.050 |
Why?
| Phenazines | 1 | 2002 | 9 | 0.050 |
Why?
| Nitrogen Isotopes | 1 | 2003 | 55 | 0.050 |
Why?
| Conscious Sedation | 1 | 2003 | 78 | 0.050 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2003 | 86 | 0.050 |
Why?
| Angiogenesis Inhibitors | 1 | 2004 | 212 | 0.050 |
Why?
| Mice | 5 | 2020 | 14679 | 0.050 |
Why?
| Maximum Tolerated Dose | 1 | 2003 | 182 | 0.050 |
Why?
| Receptor, ErbB-2 | 1 | 2004 | 299 | 0.050 |
Why?
| Infusions, Intravenous | 1 | 2003 | 368 | 0.050 |
Why?
| Proteins | 1 | 2007 | 890 | 0.050 |
Why?
| Aged, 80 and over | 4 | 2011 | 6296 | 0.050 |
Why?
| Mice, Nude | 2 | 2019 | 625 | 0.050 |
Why?
| Gene Transfer, Horizontal | 2 | 2014 | 27 | 0.050 |
Why?
| Treatment Outcome | 4 | 2014 | 9006 | 0.050 |
Why?
| ErbB Receptors | 1 | 2004 | 553 | 0.050 |
Why?
| Stents | 1 | 2004 | 463 | 0.050 |
Why?
| Combined Modality Therapy | 3 | 2011 | 1114 | 0.040 |
Why?
| Germany | 2 | 2014 | 84 | 0.040 |
Why?
| Neoadjuvant Therapy | 2 | 2014 | 305 | 0.040 |
Why?
| Sleep Apnea, Obstructive | 1 | 2003 | 196 | 0.040 |
Why?
| Disease Models, Animal | 2 | 2020 | 3470 | 0.040 |
Why?
| Female | 10 | 2019 | 59115 | 0.040 |
Why?
| Nitrites | 1 | 2020 | 74 | 0.040 |
Why?
| Genomics | 2 | 2018 | 625 | 0.040 |
Why?
| Drug Resistance, Bacterial | 1 | 2020 | 155 | 0.040 |
Why?
| Metabolic Networks and Pathways | 1 | 2020 | 167 | 0.040 |
Why?
| Synteny | 1 | 2018 | 16 | 0.040 |
Why?
| Male | 9 | 2019 | 55112 | 0.040 |
Why?
| Radiotherapy Dosage | 2 | 2011 | 242 | 0.040 |
Why?
| Drug Synergism | 1 | 2018 | 312 | 0.040 |
Why?
| Th1 Cells | 1 | 2018 | 123 | 0.040 |
Why?
| CpG Islands | 1 | 2018 | 118 | 0.040 |
Why?
| Biofilms | 1 | 2020 | 220 | 0.040 |
Why?
| Epigenomics | 1 | 2018 | 98 | 0.040 |
Why?
| Pseudomonas aeruginosa | 1 | 2020 | 297 | 0.040 |
Why?
| Down-Regulation | 1 | 2020 | 593 | 0.040 |
Why?
| Rabbits | 1 | 2019 | 713 | 0.040 |
Why?
| Cytochrome-c Peroxidase | 1 | 2016 | 1 | 0.030 |
Why?
| Heme | 1 | 2016 | 52 | 0.030 |
Why?
| Gene Deletion | 2 | 2008 | 351 | 0.030 |
Why?
| Survival Rate | 2 | 2014 | 1634 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 2 | 2011 | 1822 | 0.030 |
Why?
| Oxidoreductases | 1 | 2016 | 89 | 0.030 |
Why?
| Membrane Potentials | 1 | 2016 | 246 | 0.030 |
Why?
| Monocytes | 1 | 2018 | 499 | 0.030 |
Why?
| Polymorphism, Genetic | 2 | 2008 | 603 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2018 | 1214 | 0.030 |
Why?
| Adult | 5 | 2014 | 30245 | 0.030 |
Why?
| Immunotherapy | 1 | 2018 | 472 | 0.030 |
Why?
| Chromatin | 1 | 2018 | 418 | 0.030 |
Why?
| Switzerland | 1 | 2014 | 20 | 0.030 |
Why?
| Transcription Termination, Genetic | 1 | 2014 | 12 | 0.030 |
Why?
| Solid-Phase Synthesis Techniques | 1 | 2014 | 12 | 0.030 |
Why?
| Base Sequence | 2 | 2008 | 2080 | 0.030 |
Why?
| Mice, Inbred C57BL | 2 | 2018 | 4617 | 0.030 |
Why?
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2013 | 10 | 0.030 |
Why?
| Hominidae | 1 | 2014 | 79 | 0.030 |
Why?
| Protein Conformation | 1 | 2016 | 798 | 0.030 |
Why?
| Age Distribution | 1 | 2014 | 341 | 0.030 |
Why?
| Sex Distribution | 1 | 2014 | 336 | 0.030 |
Why?
| Lung Diseases | 1 | 2020 | 688 | 0.030 |
Why?
| Prospective Studies | 3 | 2014 | 6189 | 0.030 |
Why?
| Cisplatin | 1 | 2014 | 261 | 0.030 |
Why?
| Phosphatidylcholines | 1 | 2013 | 132 | 0.030 |
Why?
| Colloids | 1 | 2013 | 56 | 0.030 |
Why?
| Dielectric Spectroscopy | 1 | 2012 | 1 | 0.030 |
Why?
| Selection, Genetic | 1 | 2014 | 227 | 0.030 |
Why?
| Bayes Theorem | 1 | 2014 | 325 | 0.030 |
Why?
| Madagascar | 1 | 2012 | 41 | 0.030 |
Why?
| Click Chemistry | 1 | 2013 | 48 | 0.030 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 237 | 0.020 |
Why?
| Disease Progression | 2 | 2011 | 2364 | 0.020 |
Why?
| Cell Differentiation | 1 | 2018 | 1681 | 0.020 |
Why?
| Coumarins | 1 | 2011 | 20 | 0.020 |
Why?
| Nitrophenols | 1 | 2011 | 32 | 0.020 |
Why?
| Protein Binding | 1 | 2016 | 1867 | 0.020 |
Why?
| Pemetrexed | 1 | 2011 | 27 | 0.020 |
Why?
| Transcription Factors | 1 | 2018 | 1497 | 0.020 |
Why?
| Biphenyl Compounds | 1 | 2011 | 50 | 0.020 |
Why?
| Spectrum Analysis | 1 | 2011 | 83 | 0.020 |
Why?
| Cell Membrane | 1 | 2013 | 663 | 0.020 |
Why?
| Infusion Pumps, Implantable | 1 | 2010 | 20 | 0.020 |
Why?
| Gene Expression Regulation | 1 | 2018 | 2293 | 0.020 |
Why?
| Adenocarcinoma | 2 | 2007 | 787 | 0.020 |
Why?
| 3' Flanking Region | 1 | 2008 | 7 | 0.020 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2008 | 147 | 0.020 |
Why?
| Feasibility Studies | 1 | 2011 | 737 | 0.020 |
Why?
| Liver Neoplasms, Experimental | 1 | 2007 | 26 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2010 | 809 | 0.020 |
Why?
| Species Specificity | 1 | 2008 | 531 | 0.020 |
Why?
| Risk Factors | 2 | 2014 | 8606 | 0.020 |
Why?
| Endogenous Retroviruses | 1 | 2007 | 19 | 0.020 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 104 | 0.020 |
Why?
| Software Design | 1 | 2006 | 24 | 0.020 |
Why?
| Exons | 1 | 2007 | 300 | 0.020 |
Why?
| Quaternary Ammonium Compounds | 1 | 2006 | 44 | 0.020 |
Why?
| Cations | 1 | 2006 | 77 | 0.020 |
Why?
| Alleles | 1 | 2008 | 781 | 0.020 |
Why?
| Clinical Trials, Phase III as Topic | 1 | 2006 | 82 | 0.020 |
Why?
| Patient Compliance | 1 | 2010 | 523 | 0.020 |
Why?
| Precancerous Conditions | 1 | 2007 | 153 | 0.020 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2006 | 80 | 0.020 |
Why?
| Cell Lineage | 1 | 2007 | 305 | 0.020 |
Why?
| Fatal Outcome | 1 | 2006 | 280 | 0.020 |
Why?
| Colonic Neoplasms | 1 | 2007 | 210 | 0.020 |
Why?
| Biological Evolution | 1 | 2008 | 392 | 0.020 |
Why?
| Neoplasms | 1 | 2018 | 2082 | 0.020 |
Why?
| BALB 3T3 Cells | 1 | 2004 | 1 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2006 | 315 | 0.010 |
Why?
| Mutation | 1 | 2014 | 3313 | 0.010 |
Why?
| Melanoma, Experimental | 1 | 2004 | 89 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2006 | 716 | 0.010 |
Why?
| Software | 1 | 2007 | 525 | 0.010 |
Why?
| DNA Probes | 1 | 2002 | 59 | 0.010 |
Why?
| Cell Division | 1 | 2004 | 745 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2007 | 1925 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 2006 | 1328 | 0.010 |
Why?
| Internet | 1 | 2006 | 590 | 0.010 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2004 | 693 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 1136 | 0.010 |
Why?
| Mice, Knockout | 1 | 2007 | 2523 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 737 | 0.010 |
Why?
| Models, Biological | 1 | 2007 | 1589 | 0.010 |
Why?
| Age Factors | 1 | 2007 | 2875 | 0.010 |
Why?
| Phosphorylation | 1 | 2004 | 1537 | 0.010 |
Why?
| Retrospective Studies | 2 | 2006 | 12504 | 0.010 |
Why?
| Algorithms | 1 | 2006 | 1462 | 0.010 |
Why?
| Palliative Care | 1 | 2004 | 635 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2004 | 2690 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2006 | 2269 | 0.010 |
Why?
| Prognosis | 1 | 2004 | 3318 | 0.010 |
Why?
| Risk Assessment | 1 | 2004 | 2953 | 0.010 |
Why?
|
|
Meyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|